Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.

Profit growth above 25%Results View source PDF Explain this filing

DIVISLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.5%Reaction day

₹6410.50

prior close

₹6258.00

announcement price

In-mkt

timing

Nifty 100market · index membership as recorded later (tracked since Jun 2026)-0.4%-3.1% vs market

Pharmaceuticals peers, median of 149sector-1.7%-1.9% vs sector

On the reaction day the stock moved 3.1 pts less than Nifty 100 and 1.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.8

10m

-1.4

15m

-0.5

30m

-0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.5-0.4-3.1-1.7-1.9

Next day

-4.4-0.3-4.1-1.4-3.0

-7.8-1.3-6.5-2.0-5.8

-6.7-0.3-6.4-2.0-4.7

-6.9-0.7-6.3-1.7-5.2

-5.1-0.1-5.0-1.8-3.3

-4.0+0.9-4.9-1.9-2.1

15d

-4.9-1.0-3.9-3.6-1.4

-5.9+0.6-6.5-2.5-3.4

-9.3+1.9-11.2-3.3-6.0

+7.2+3.6+3.7-5.7+12.9

UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 149Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Divi's Laboratories reported consolidated revenue from operations of ₹2,410 crores in Q1 FY26, up about 13.8% from ₹2,118 crores in Q1 FY25. Consolidated total income rose to ₹2,529 crores from ₹2,197 crores, a 15% increase. Consolidated profit after tax (PAT) jumped to ₹545 crores from ₹430 crores, a 26.7% year-on-year rise, while profit before tax grew to ₹733 crores from ₹604 crores. On a standalone basis, PAT grew even stronger at 29.5% to ₹557 crores, and EPS stood at ₹20.95 (standalone) / ₹20.49 (consolidated). The quarter also included a forex gain of ₹39 crores versus a ₹1 crore loss a year ago. Statutory auditor Price Waterhouse issued an unmodified limited review report on both standalone and consolidated results.

Likely market impact

Strong profit growth driven by operating leverage and a favourable forex tailwind, despite revenue rising in low double digits. Clean audit report and no exceptional items support a positive read for shareholders, though sequential PBT did dip from ₹864 crores in Q4 FY25 to ₹733 crores in Q1 FY26.